Evaluation of methotrexate toxicity
dc.contributor.author | Рябенко, Тетяна Василівна | |
dc.contributor.author | Riabenko, Tetiana Vasylivna | |
dc.contributor.author | Гула, Вікторія Іванівна | |
dc.contributor.author | Hula, Viktoriia Ivanivna | |
dc.contributor.author | Кореньков, Олексій Володимирович | |
dc.contributor.author | Korenkov, Oleksii Volodymyrovych | |
dc.contributor.author | Понирко, Аліна Олексіївна | |
dc.contributor.author | Ponyrko, Alina Oleksiivna | |
dc.contributor.author | Теслик, Тетяна Петрівна | |
dc.contributor.author | Teslyk, Tetiana Petrivna | |
dc.contributor.author | Дмитрук, Сергій Миколайович | |
dc.contributor.author | Dmytruk, Serhii Mykolaiovych | |
dc.contributor.author | Ілляшенко, Вячеслав Юрійович | |
dc.contributor.author | Illiashenko, Viacheslav Yu. | |
dc.contributor.author | Дудченко, Євгеній Сергійович | |
dc.contributor.author | Dudchenko, Yevhenii Serhiiovych | |
dc.date.accessioned | 2024-05-13T07:33:29Z | |
dc.date.available | 2024-05-13T07:33:29Z | |
dc.date.issued | 2023 | |
dc.description.abstract | The article analyzes literary sources on the study of the toxic effects of methotrexate in the treatment of various diseases and examines scientific data on methods of preventing their development. According to the literary information, the main toxic effects of methotrexate manifest as damage to the liver, kidneys, bone marrow, lungs, digestive system, and skin. Methotrexate exhibits pronounced embryotoxic and teratogenic effects. Monitoring of blood test parameters and selection of an optimal dose will minimize methotrexate toxic effects and help in achieving success in the treatment. | en_US |
dc.identifier.citation | Riabenko T. V., Hula V. I., Korenkov O. V., Ponyrko A. A., Teslyk T. P. et al. Evaluation of methotrexate toxicity. Azerbaijan Medical Journal. 2023;(4).141-146. DOI: 10.34921/amj.2023.4.020. | en_US |
dc.identifier.uri | https://essuir.sumdu.edu.ua/handle/123456789/95266 | |
dc.language.iso | uk | en_US |
dc.publisher | Izdatel'stvo Elm | en_US |
dc.rights.uri | CC BY 4.0 | en_US |
dc.subject | methotrexate | en_US |
dc.subject | toxisity | en_US |
dc.subject | side effects | en_US |
dc.subject | clinical evaluation | en_US |
dc.subject | bone marrow disease | en_US |
dc.subject | teratogenesis | en_US |
dc.subject | digestive system disease | en_US |
dc.subject | embryotoxicity | en_US |
dc.subject | skin disease | en_US |
dc.subject | lung disease | en_US |
dc.subject | liver disease | en_US |
dc.subject | kidney disease | en_US |
dc.title | Evaluation of methotrexate toxicity | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Riabenko_methotrexate_2023.pdf
- Size:
- 373.49 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 3.96 KB
- Format:
- Item-specific license agreed upon to submission
- Description: